https://www.pinsentmasons.com/about-us/announcements/pinsent-masons-advises-horizon-3-healthcare-on-investment-in-xeltis
Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis
Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a...
pinsent masonsadviseshorizonhealthcareinvestment
https://www.eu-startups.com/2026/07/dutch-us-medtech-xeltis-raises-e20-5-million-to-advance-artificial-vessels-and-valves-replaced-by-patients-own-tissue/
Dutch-US MedTech Xeltis raises €20.5 million to advance artificial vessels and valves replaced by...
Jul 28, 2026 - Xeltis, a commercial-stage MedTech company based in the Netherlands and the USA, developing artificial vessels and valves that are gradually replaced by
https://www.globenewswire.com/news-release/2026/07/28/3334018/0/en/xeltis-raises-an-additional-20-5m-of-funding-to-advance-axess-toward-fda-approval-and-us-commercial-launch.html
Xeltis raises an additional €20.5m of funding to advance
Jul 28, 2026 - Xeltis has raised €20.5m of funding from new and excisting shareholders to advance aXess™ toward FDA approval and US commercial launch...
raisesadditionalfundingadvance